199 related articles for article (PubMed ID: 10949925)
1. Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma.
Lee YI; Lee S; Das GC; Park US; Park SM; Lee YI
Oncogene; 2000 Aug; 19(33):3717-26. PubMed ID: 10949925
[TBL] [Abstract][Full Text] [Related]
2. The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Lee YI; Lee S; Lee Y; Bong YS; Hyun SW; Yoo YD; Kim SJ; Kim YW; Poo HR
Oncogene; 1998 May; 16(18):2367-80. PubMed ID: 9620554
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein transactivates insulin-like growth factor II gene transcription through acting concurrently on Egr1 and Sp1 sites.
Lee S; Park U; Lee YI
Virology; 2001 May; 283(2):167-77. PubMed ID: 11336542
[TBL] [Abstract][Full Text] [Related]
4. Activation of the IGF-II gene by HBV-X protein requires PKC and p44/p42 map kinase signalings.
Kang-Park S; Lee JH; Shin JH; Lee YI
Biochem Biophys Res Commun; 2001 May; 283(2):303-7. PubMed ID: 11327698
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the insulin-like growth factor I (IGF-I) receptor gene in hepatocellular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product.
Kim SO; Park JG; Lee YI
Cancer Res; 1996 Aug; 56(16):3831-6. PubMed ID: 8706031
[TBL] [Abstract][Full Text] [Related]
6. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
7. Oncogene-induced up-regulation of Caco-2 cell proliferation involves IGF-II gene activation through a protein kinase C-mediated pathway.
Cadoret A; Baron-Delage S; Bertrand F; Kornprost M; Groyer A; Gespach C; Capeau J; Cherqui G
Oncogene; 1998 Aug; 17(7):877-87. PubMed ID: 9780004
[TBL] [Abstract][Full Text] [Related]
8. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
Henkler F; Waseem N; Golding MH; Alison MR; Koshy R
Cancer Res; 1995 Dec; 55(24):6084-91. PubMed ID: 8521397
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional repression of the human p53 gene by hepatitis B viral core protein (HBc) in human liver cells.
Kwon JA; Rho HM
Biol Chem; 2003 Feb; 384(2):203-12. PubMed ID: 12675512
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.
Xu D; Wang Q; Gruber A; Björkholm M; Chen Z; Zaid A; Selivanova G; Peterson C; Wiman KG; Pisa P
Oncogene; 2000 Oct; 19(45):5123-33. PubMed ID: 11064449
[TBL] [Abstract][Full Text] [Related]
11. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
12. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer.
Webster NJ; Resnik JL; Reichart DB; Strauss B; Haas M; Seely BL
Cancer Res; 1996 Jun; 56(12):2781-8. PubMed ID: 8665514
[TBL] [Abstract][Full Text] [Related]
13. p53 is a NF-Y- and p21-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
FEBS Lett; 2005 Feb; 579(5):1001-7. PubMed ID: 15710382
[TBL] [Abstract][Full Text] [Related]
14. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
[TBL] [Abstract][Full Text] [Related]
15. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.
Ragimov N; Krauskopf A; Navot N; Rotter V; Oren M; Aloni Y
Oncogene; 1993 May; 8(5):1183-93. PubMed ID: 8479742
[TBL] [Abstract][Full Text] [Related]
16. HBV DNA can bind to P53 protein and influence p53 transactivation in hepatoma cells.
Qu J; Lin J; Zhang S; Zhu Z; Ni C; Zhang S; Gao H; Zhu M
Biochem Biophys Res Commun; 2009 Aug; 386(3):504-9. PubMed ID: 19540192
[TBL] [Abstract][Full Text] [Related]
17. Using DNA microarray to identify Sp1 as a transcriptional regulatory element of insulin-like growth factor 1 in cardiac muscle cells.
Li T; Chen YH; Liu TJ; Jia J; Hampson S; Shan YX; Kibler D; Wang PH
Circ Res; 2003 Dec; 93(12):1202-9. PubMed ID: 14593001
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X mutants derived from human hepatocellular carcinoma retain the ability to abrogate p53-induced apoptosis.
Huo TI; Wang XW; Forgues M; Wu CG; Spillare EA; Giannini C; Brechot C; Harris CC
Oncogene; 2001 Jun; 20(28):3620-8. PubMed ID: 11439325
[TBL] [Abstract][Full Text] [Related]
19. Sp1-mediated transactivation of LamC1 promoter and coordinated expression of laminin-gamma1 and Sp1 in human hepatocellular carcinomas.
Liétard J; Musso O; Théret N; L'Helgoualc'h A; Campion JP; Yamada Y; Clément B
Am J Pathol; 1997 Dec; 151(6):1663-72. PubMed ID: 9403717
[TBL] [Abstract][Full Text] [Related]
20. [Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].
Xue KX
Ai Zheng; 2005 Jun; 24(6):757-68. PubMed ID: 15946497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
